Study of Safety, Tolerability & Efficacy of CK-2017357 in Amyotrophic Lateral Sclerosis (ALS)
Status:
Completed
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to evaluate the safety and effectiveness of CK-2017357
when taken with or without riluzole (also called Rilutek®) in patients with Amyotrophic
Lateral Sclerosis (ALS).